Mechanism of PAP I gene induction during hepatocarcinogenesis: clinical implications
1996

PAP I Gene Induction in Liver Cancer

Sample size: 207 publication Evidence: moderate

Author Information

Author(s): NJ Dusettil, G Montalto, EM Ortiz, L Masciotra, J-C Dagorn, JL Iovanna

Hypothesis

The study investigates the molecular mechanisms of PAP I gene induction during hepatocarcinogenesis.

Conclusion

PAP I expression in hepatocarcinoma is linked to the inactivation of its silencer element, making it a potential marker for liver cancer development.

Supporting Evidence

  • PAP I levels were normal in chronic hepatitis, significantly higher in cirrhosis, and strongly elevated in hepatocarcinoma.
  • 64% of hepatocarcinoma patients had PAP values above the normal threshold.
  • Negative correlations were found between PAP levels and albumin, prothrombin, and platelet counts.

Takeaway

This study found that a protein called PAP I is made more when liver cancer is present, which could help doctors spot the disease earlier.

Methodology

The study involved molecular studies, cell culture, transfection assays, and clinical evaluations of serum PAP I levels in patients.

Limitations

The study is retrospective and may have sampling heterogeneity.

Participant Demographics

The study included 207 patients with chronic hepatitis, liver cirrhosis, hepatocarcinoma, and healthy controls, with a mean age ranging from 43.5 to 66.4 years.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication